Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Rheumatoid arthritis

Can we achieve true drug-free remission in patients with RA?

Since the introduction of new biologic agents and intensive treatment strategies that aim to tightly control disease activity, clinical remission has become a realistic target in patients with rheumatoid arthritis. Once patients are in continuous remission, however, is it realistic to consider withdrawing DMARD therapy?

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. van Vollenhoven, R. F. Treatment of rheumatoid arthritis: state of the art. Nat. Rev. Rheumatol. 5, 531–541 (2009).

    Article  CAS  Google Scholar 

  2. Bakker, M. F., Jacobs, J. W. G., Verstappen, S. M. M & Bijlsma, J. W. J. Tight control in the treatment of rheumatoid arthritis: efficacy and feasibility. Ann. Rheum. Dis. 66 (Suppl. 3), iii56–iii60 (2007).

    PubMed  PubMed Central  Google Scholar 

  3. Mader, R. & Keystone, E. Optimizing treatment with biologics. J. Rheumatol. 80 (Suppl.), 16–24 (2007).

    CAS  Google Scholar 

  4. Combe, B. et al. EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann. Rheum. Dis. 66, 34–45 (2007).

    Article  CAS  Google Scholar 

  5. Tiippana-Kinnunen, T., Paimela, L., Kautiainen, H., Laasonen, L. & Leirisalo-Repo, M. Can disease-modifying anti-rheumatic drugs be discontinued in long-standing rheumatoid arthritis? A 15-year follow-up. Scand. J. Rheumatol. doi:10.1080/03009740903042394.

  6. Pinals, R. S., Masi, A. T. & Larsen, R. A. Preliminary criteria for clinical remission in rheumatoid arthritis. Arthritis Rheum. 24, 1308–1315 (1981).

    Article  CAS  Google Scholar 

  7. ten Wolde, S. et al. Randomised placebo-controlled study of stopping second-line drugs in rheumatoid arthritis. Lancet 347, 347–352 (1996).

    Article  CAS  Google Scholar 

  8. van der Kooij, S. M. et al. Drug-free remission, functioning and radiographic damage after 4 years of response-driven treatment in patients with recent-onset rheumatoid arthritis. Ann. Rheum. Dis. 68, 914–921 (2009).

    Article  CAS  Google Scholar 

  9. van der Woude, D. et al. Prevalence of and predictive factors for sustained disease-modifying antirheumatic drug-free remission in rheumatoid arthritis. Results from two large early arthritis cohorts. Arthritis Rheum. 60, 2262–2271 (2009).

    Article  Google Scholar 

Download references

Acknowledgements

This work was supported by the MASTERSWITCH Integrated Project, which is funded by the Eurpoean Union under the Seventh Framework Program (FP7).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yvonne P. M. Goekoop-Ruiterman.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Goekoop-Ruiterman, Y., Huizinga, T. Can we achieve true drug-free remission in patients with RA?. Nat Rev Rheumatol 6, 68–70 (2010). https://doi.org/10.1038/nrrheum.2009.253

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrrheum.2009.253

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing